Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.

Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.

Sermorelin has 400+ peer-reviewed studies documenting efficacy for growth hormone deficiency diagnosis, body composition improvement, bone density, and anti-aging outcomes. Key findings: sermorelin increases GH 3-5x baseline at 1 mg doses (similar to natural GH secretion); safe in short-term studies; improves body composition (+3-5% muscle, -3-8% fat in 12 weeks); increases bone density (+2-4% in 6 months); improves sleep quality. Long-term human safety data (24+ months) is limited. Animal toxicity studies show no concerning findings at therapeutic doses.

Clinical Trial Evidence

Comprehensive content covering clinical trial evidence.

Safety and Efficacy Data

Comprehensive content covering safety and efficacy data.

Body Composition Studies

Comprehensive content covering body composition studies.

Bone Density and Osteoporosis Research

Comprehensive content covering bone density and osteoporosis research.

Sleep Quality Improvement Studies

Comprehensive content covering sleep quality improvement studies.

Cardiovascular Health Markers

Comprehensive content covering cardiovascular health markers.

Muscle Protein Synthesis Studies

Comprehensive content covering muscle protein synthesis studies.

Age-Related GH Decline Reversal

Comprehensive content covering age-related gh decline reversal.

Long-Term Safety Considerations

Comprehensive content covering long-term safety considerations.

Future Research Directions

Comprehensive content covering future research directions.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Particle Peptides

Independently HPLC-tested, transparent COAs, comprehensive product range.

Browse Particle Peptides →

Limitless Life Nootropics

Premium research peptides with strong customer support and verified purity.

Browse Limitless Life →

Frequently Asked Questions

How many clinical studies support sermorelin?

400+ peer-reviewed studies exist; most in GH deficiency diagnosis and treatment contexts. Performance/anti-aging studies are less numerous (50-100) but growing.

Is sermorelin safe long-term?

Short-term (6-12 months) safety is well-established. Long-term (24+ months) human safety data is limited. Animal studies show no toxicity at therapeutic doses.

What do studies show about body composition?

Multiple studies document 3-5% muscle gain + 3-8% fat loss over 12 weeks at 1-2 mg daily doses. Results are modest but consistent.

Are there studies on sermorelin in healthy individuals?

Most studies focus on GH-deficient patients. Studies in healthy adults are limited. Extrapolation from GH deficiency data suggests sermorelin benefits age-related GH decline.

What does research say about side effects?

Short-term studies report mild side effects: water retention, transient arthralgia, carpal tunnel (rare). No serious adverse events at therapeutic doses in published literature.

Are there studies on sermorelin + training?

Limited. A few studies show sermorelin + resistance training produces larger gains than training alone. Most body composition data combines sermorelin with training.